1-20 of 43
Biree Andemariam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Community Health Worker Engagement with Adolescents and Young Adults with Sickle Cell Disease: Findings from the Comets Study

Jayanne Forrest, Caren Steinway, Eelia Shaw, Sophia Jan, Banu Aygun, Abena Appiah-Kubi, Nataly Apollonsky, Donna Boruchov, Omar Niss, Biree Andemariam, Kim Smith-Whitley, Symme Trachtenberg, Tanisha Belton
Journal: Blood
Blood (2024) 144 (Supplement 1): 617.
https://doi.org/10.1182/blood-2024-206036
Published: 2024
Journal Articles

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Sophia Delicou, Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen, Jessie Githanga, Adlette Inati, Ibrahim Idris, Sunil Navani, Eric Wu, Andrew Eisenberger
Journal: Blood
Blood (2024) 144 (Supplement 1): 179.
https://doi.org/10.1182/blood-2024-204962
Published: 2024
Journal Articles

How People with Sickle Cell Disease Rate Motivators is Associated with the Likelihood of Wanting to Participate in a Clinical Trial: Findings from the Global LISTEN Survey

Biree Andemariam, Johnny Mahlangu, Raffaella Colombatti, John Waller, Samar Al-Behaisi, Gareth Morrell, John James
Journal: Blood
Blood (2024) 144 (Supplement 1): 1137.
https://doi.org/10.1182/blood-2024-200009
Published: 2024
Journal Articles

Motivators and Barriers for People with Sickle Cell Disease Participating in Clinical Trials: United States Findings from the Listen Survey

Biree Andemariam, Adam Wufsus, Erik Hecht, Cassandra Trimnell
Journal: Blood
Blood (2024) 144 (Supplement 1): 1139.
https://doi.org/10.1182/blood-2024-194253
Published: 2024
Journal Articles

Characterizing People with Sickle Cell Disease Who Share Attitudes Regarding Clinical Trial Participation: Findings from the Global LISTEN Survey

Johnny Mahlangu, John James, Biree Andemariam, John Waller, Samar Al-Behaisi, Gareth Morrell, Raffaella Colombatti, Cassandra Trimnell
Journal: Blood
Blood (2024) 144 (Supplement 1): 1135.
https://doi.org/10.1182/blood-2024-200550
Published: 2024
Journal Articles

Community Health Worker and Mobile Health Programs to Help Young Adults with Sickle Cell Disease Transition to Using Adult Healthcare Services – the Comets Study; Results from Patient-Reported Outcomes at 6 Months

Sophia Jan, Caren Steinway, Tanisha Belton, Justine Shults, Laura Bennett, Heather Griffis, Banu Aygun, Abena Appiah-Kubi, Nataly Apollonsky, Donna Boruchov, Omar Niss, Lisa A. Schwartz, Lori E. Crosby, Lamia Barakat, Biree Andemariam, David Rubin, Kim Smith-Whitley
Journal: Blood
Blood (2024) 144 (Supplement 1): 1066.
https://doi.org/10.1182/blood-2024-205273
Published: 2024
Journal Articles

Clinical Complications and Healthcare Resource Utilization in Medicaid and Commercially Insured Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions

Chuka Udeze, Michelle Jerry, Kristin Evans, Nanxin Li, Siddharth Jain, Biree Andemariam
Journal: Blood
Blood (2024) 144 (Supplement 1): 7661.
https://doi.org/10.1182/blood-2024-204008
Published: 2024
Journal Articles

Adherence, Clinical and Economic Outcomes in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises Treated with L-Glutamine, Voxelotor, or Crizanlizumab Covered By Medicaid and Commercial Insurance in the United States

Chuka Udeze, Michelle Jerry, Kristin Evans, Nanxin Li, Siddharth Jain, Biree Andemariam
Journal: Blood
Blood (2024) 144 (Supplement 1): 7660.
https://doi.org/10.1182/blood-2024-203628
Published: 2024
Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Modupe Idowu, Michael R. DeBaun, Arthur Burnett, Deepika S. Darbari, Soheir Adam, Alan Randall Anderson, Julie Kanter, Henny H. Billett, Darla K. Liles, Robert S. Nickel, Laura M. Decastro, Biree Andemariam, Gershwin Theophilus Blyden, Matthew M. Heeney, Poornima Ramadas, Morgan L. McLemore, Yogita Kolekar, Dramane Laine, Jincy Paulose, Rajendra Sarkar, Mary Beth Vignogna, Fuad El Rassi
Journal: Blood
Blood (2023) 142 (Supplement 1): 146.
https://doi.org/10.1182/blood-2023-179042
Published: 2023
Journal Articles

Motivators and Barriers for People with Sickle Cell Disease Participating in Clinical Trials: Global Findings from the LISTEN Survey

John James, Biree Andemariam, Johnny Mahlangu, Raffaella Colombatti, John Waller, Samar Al-Behaisi, Adam Wufsus, Gareth Morrell, Cassandra Trimnell
Journal: Blood
Blood (2023) 142 (Supplement 1): 2498.
https://doi.org/10.1182/blood-2023-181910
Published: 2023
Journal Articles

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Biree Andemariam, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2023) 142 (Supplement 1): 7224.
https://doi.org/10.1182/blood-2023-173457
Published: 2023
Journal Articles

Cross-Community Collaboration and Data Collection to Optimize Patient Care in Hemolytic Anemias

Biree Andemariam, Ninamaria Badalamenti, Rae Blaylark, Ralph Colasanti, Raffaella Colombatti, Rachael F. Grace, Charles R. Jonassaint, Kevin H.M. Kuo, Laurice M Levine, Clarisse Lobo, Tamara Schyrver, Sujit Sheth, Cassandra Trimnell, Alejandra Watson, Jill Welle, Teonna Woolford, Holly John, Janie Davis, Ahmar U Zaidi, Eva Gallagher, Sarah Gheuens, Nirmish Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 3692.
https://doi.org/10.1182/blood-2023-181632
Published: 2023
Journal Articles

Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study

Biree Andemariam, Henny H. Billett, William B Ershler, Shayla Bergmann, Vishwas S. Sakhalkar, Alicia Chang, Payal Desai, Nirmish Shah, Sharon Pennington, Robin E. Miller, Laura M. Decastro, Michelle Xu, Brooke Hayward, Ching-Ray Yu, Darla K. Liles
Journal: Blood
Blood (2023) 142 (Supplement 1): 2499.
https://doi.org/10.1182/blood-2023-188746
Published: 2023
Journal Articles

Setting Industry Standards for Patient Engagement, Partnership, Allyship and Care: The Patient Vision Project

Biree Andemariam, Tamara Schryver, Rae Blaylark, Ralph Colasanti, Nirmish Shah, Charles R. Jonassaint, Rucha Shah, Cassandra Trimnell, Teonna Woolford, Janie Davis, Eva Gallagher, Ahmar U Zaidi, Holly John, Sujit Sheth
Journal: Blood
Blood (2023) 142 (Supplement 1): 7233.
https://doi.org/10.1182/blood-2023-181791
Published: 2023
Journal Articles

A Phase 2, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients with Sickle Cell Disease

Biree Andemariam, Vivien A. Sheehan, Moayed Hamza, Kirsty Kelly, John Climax
Journal: Blood
Blood (2023) 142 (Supplement 1): 1159.
https://doi.org/10.1182/blood-2023-188727
Published: 2023
Journal Articles

Estimating Sickle Cell Disease Prevalence By State: A Model Using US-Born and Foreign-Born State-Specific Population Data

Yao Fu, Biree Andemariam, Claire Herman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3900.
https://doi.org/10.1182/blood-2023-189287
Published: 2023
Journal Articles

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results

Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse LC Lobo, Swee Lay Thein, Biree Andemariam, Obiageli E Nnodu, Adlette Inati, Alexander K Glaros, Sara Teresinha Olalla Saad, Pablo Bartolucci, Raffaella Colombatti, Ali T Taher, Miguel R Abboud, Abdulafeez Oluyadi, Varsha Iyer, Ophelia Yin, Susan Morris, Amber M Yates, Hui Shao, Spurthi Patil, Rolandas Urbstonaitis, Ahmar U Zaidi, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 271.
https://doi.org/10.1182/blood-2023-187033
Published: 2023
Journal Articles

Real-World Outcomes in Adult Sickle Cell Disease Patients Treated with Crizanlizumab, Voxelotor or Both

Abisola Baruwa Etti, Chia-ling Kuo, Lucas Da Cunha Godoy, Biree Andemariam
Journal: Blood
Blood (2022) 140 (Supplement 1): 8292–8293.
https://doi.org/10.1182/blood-2022-170808
Published: 2022
Journal Articles

Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)

Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett
Journal: Blood
Blood (2022) 140 (Supplement 1): 1636–1638.
https://doi.org/10.1182/blood-2022-157004
Published: 2022
Journal Articles

Clinical and Economic Outcomes in Patients with Transfusion-Dependent β-Thalassemia and Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises Receiving Hematopoietic Stem Cell Transplants in the United States

Chuka Udeze, Kristin Evans, Yoojung Yang, Timothy Lillehaugen, Janna Manjelievskaia, Urvi Mujumdar, Nanxin Li, Biree Andemariam
Journal: Blood
Blood (2022) 140 (Supplement 1): 10741–10742.
https://doi.org/10.1182/blood-2022-157601
Published: 2022